ENGENZLA Trademark

Trademark Overview

On Thursday, August 20, 2015, a trademark application was filed for ENGENZLA with the United States Patent and Trademark Office. The USPTO has given the ENGENZLA trademark a serial number of 86730684. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, September 3, 2015. This trademark is owned by Pfizer Inc.. The ENGENZLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
engenzla

General Information

Serial Number86730684
Word MarkENGENZLA
Filing DateThursday, August 20, 2015
Status601 - ABANDONED - EXPRESS
Status DateThursday, September 3, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 25, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Thursday, September 3, 2015ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Thursday, September 3, 2015ABANDONMENT - EXPRESS MAILED
Wednesday, September 2, 2015TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, August 25, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 24, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

engenzla preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases